A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology

NCT02204345 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: RO5479599

Sponsor

Hoffmann-La Roche